NASDAQ:ELVN | Income Statement | Enliven Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$29M$37.21M-$37.21M$4.72M-$32.49M-$0.49-$0.4966,171,58166,171,581
2026-03-31$20.69M$27.82M-$27.82M$4.2M-$23.63M-$0.38-$0.3862,799,32662,799,326
2025-12-31$21.25M$34.29M-$34.29M$4.62M$0.00-$29.67M-$0.48-$0.481,870,0711,870,071
2025-09-30$18.23M$25.1M-$25.1M$4.95M$0.00-$20.15M-$0.32-$0.3262,093,79562,093,795
2025-06-30$21.49M$28.58M-$28.58M$3.25M$0.00-$25.34M-$0.49-$0.4952,105,05252,105,052
2025-03-31$24.9M$31.69M-$31.69M$3.15M-$28.54M-$0.57-$0.5750,051,28350,051,283
2024-12-31$20.72M$26.9M-$26.9M$3.72M$0.00-$23.18M-$0.46-$0.46935,362935,362
2024-09-30$21.26M$27.07M-$27.07M$3.91M$0.00-$23.16M-$0.48-$0.4848,267,45848,267,458
2024-06-30$18.83M$24.6M-$24.6M$4.65M$232,000.00-$19.95M-$0.41-$0.4148,075,03548,075,035
2024-03-31$19.97M$25.99M-$25.99M$3.25M-$22.74M-$0.54-$0.5442,045,60842,045,608
2023-12-31$17.91M$22.73M-$22.73M$3.36M$0.00-$19.37M-$0.46-$0.461,881,1481,881,148
2023-09-30$19.61M$24.25M-$24.25M$3.48M$0.00-$20.77M-$0.51-$0.5141,030,87441,030,874
2023-06-30$15.18M$20.13M-$20.13M$3.41M-$16.72M-$0.41-$0.4140,961,02440,961,024
2023-03-31$11.88M$16.42M-$16.42M$1.69M-$14.72M-$0.80-$0.8040,961,02440,961,024
2022-12-31$8.2M$10.16M-$10.16M$613,000.00-$9.55M-$2.90-$2.9053,17053,170
2022-09-30$7.83M$10.93M-$10.93M$380,000.00-$10.55M-$3.27-$3.273,228,6923,228,692
2022-06-30$7.94M$9.02M-$9.02M$127,000.00-$8.89M-$2.86-$2.863,103,9743,103,974
2022-03-31$7.06M$8.68M-$8.68M$9,000.00-$8.67M-$3.01-$3.012,876,7792,876,779
2021-12-31$10.86M$14.33M-$14.33M$15,000.00-$14.32M-$0.53-$1.041,561,4744,013,974
2021-09-30$10.4M$13.66M-$13.66M$12,000.00-$13.65M-$0.55-$0.7424,898,34617,715,474
2021-06-30$10.07M$13.17M-$13.17M$8,000.00-$13.16M-$0.74-$0.7417,715,47417,715,474
2021-03-31$7.12M$10.28M-$10.28M$23,000.00-$10.26M17,577,454
2020-12-31$8.96M$11.55M-$11.55M$32,000.00-$11.52M1,228,362
2020-09-30$9.53M$12.49M-$12.49M$71,000.00-$12.42M17,349,813
2020-06-30$7.87M$10.3M-$10.3M$98,000.00-$10.2M17,194,795
2020-03-31$5.79M$7.35M-$7.35M$137,000.00-$7.22M3,493,359
2019-12-31$5.94M$7.48M-$7.48M$233,000.00-$7.25M-55
2019-09-30$5.14M$6.88M-$6.88M$260,000.00-$6.62M702,510
2019-06-30$4.37M$5.56M-$5.56M$160,000.00-$5.4M702,510
2019-03-31$3.56M$4.19M-$4.19M-$4.19M702,510

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$85.86M$119.66M-$119.66M$15.96M$0.00-$103.69M-$1.83-$1.8356,664,22656,664,226
2024-12-31$80.78M$104.55M-$104.55M$15.53M$232,000.00-$89.02M-$1.89-$1.8947,072,53247,072,532
2023-12-31$64.57M$83.53M-$83.53M$11.95M$0.00-$71.58M-$2.01-$2.0135,546,21535,546,215
2022-12-31$31.02M$38.79M-$38.79M$1.13M$1.58M$0.00-$37.66M-$12.05-$12.053,124,2743,124,274
2021-12-31$38.44M$51.44M-$51.44M$58,000.00-$51.38M-$51.38M-$2.37-$2.3721,661,45021,661,450
2020-12-31$32.15M$41.7M-$41.7M$338,000.00-$41.36M13,924,730
2019-12-31$19.01M$24.12M-$24.12M$653,000.00-$23.46M702,455